Home › Calculator › NTRA Dividend Calculator 2026
NTRA Dividend DRIP Calculator 2026
0.74% YieldHealthcareNatera, Inc. · NASDAQ
Price: $271.10 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When NTRA pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your NTRA snowball 📈
$10,000 in NTRA → $10.32M in 10 years · $6.19/month
About Natera, Inc. (NTRA) — Dividend Analysis 2026
Natera, Inc. is a diagnostics company focused on developing and commercializing a wide array of molecular testing services globally. Its portfolio includes several key offerings: Panorama, a non-invasive prenatal test (NIPT) that screens for chromosomal abnormalities in a fetus using a blood sample from the mother, and also determines zygosity in twin pregnancies. Vistara, designed to identify single-gene disorders by screening for specific single-gene mutations. Horizon, a comprehensive carrier screening test to determine an individual's carrier status for various genetic diseases. Spectrum, utilized during in vitro fertilization (IVF) cycles to detect chromosomal anomalies or inherited genetic conditions. Anora, a miscarriage analysis product that examines fetal chromosomes to help understand the cause of pregnancy loss. Non-invasive paternity testing, which establishes paternity during gestation using blood samples from both the pregnant mother and the alleged father. Beyond reproductive health, Natera also provides specialized tests: Signatera, a sophisticated circulating tumor DNA (ctDNA) technology capable of screening for a generic set of mutations, independent of the individual's specific tumor characteristics. Prospera, a test used to assess and monitor organ transplant rejection. Additionally, the company offers Constellation, a cloud-based software platform that provides laboratory clients with access to Natera's proprietary algorithms and bioinformatics, enabling them to validate and launch their own tests. Natera distributes its products through a direct sales team and an extensive network of approximately 100 laboratory and distribution partners. The company has strategic partnerships, including one with BGI Genomics Co., Ltd. for the development, manufacturing, and commercialization of NGS-based genetic testing assays, and another with Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. Founded in 2003, Natera, Inc. is headquartered in Austin, Texas. It was formerly known as Gene Security Network, Inc. before changing its name in 2012.
Compare NTRA with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full NTRA DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open NTRA position with:
🌍 NTRA Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold NTRA.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.74% | -2.06% | $74 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.63% | -2.17% | $63 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.59% | -2.21% | $59 / yr |
| 🇬🇧 UK ISA | 0% | 0.74% | -2.06% | $74 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.68% | -2.12% | $68 / yr |
| 🇨🇦 TFSA | 0% | 0.74% | -2.06% | $74 / yr |
| 🇨🇦 CA Taxable | 25% | 0.55% | -2.25% | $55 / yr |
| 🇦🇺 Super (pension) | 15% | 0.63% | -2.17% | $63 / yr |
| 🇦🇺 AU Taxable | 30% | 0.52% | -2.28% | $52 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.54% | -2.26% | $54 / yr |
| 🇫🇷 FR Taxable | 30% | 0.52% | -2.28% | $52 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 NTRA Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 NTRA Dividend Payment Schedule
NTRA pays quarterly — 4 times per year. Next ex-div: TBD.
📊 NTRA vs Healthcare Benchmarks
How NTRA compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for NTRA sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ NTRA Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Sale | 2026-07-15 | 390 | $273.01 | $106.5K | ||
| Sale | 2026-07-15 | 450 | $273.05 | $122.9K | ||
| Sale | 2026-07-15 | 100 | $273.68 | $27.4K | ||
| Sale | 2026-07-15 | 90 | $274.26 | $24.7K | ||
| Sale | 2026-07-15 | 180 | $274.99 | $49.5K | ||
| Sale | 2026-07-15 | 170 | $275.26 | $46.8K | ||
| Sale | 2026-07-15 | 40 | $276.38 | $11.1K | ||
| Sale | 2026-07-15 | 80 | $276.01 | $22.1K | ||
| Sale | 2026-07-15 | 135 | $274.82 | $37.1K | ||
| Sale | 2026-07-13 | 500 | $262.72 | $131.4K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Geographic Revenue Breakdown
Where NTRA earns its moneyRevenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the NTRA dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Natera, Inc. (NTRA) is currently trading at $271.10, trading near its 52-week high. The current dividend yield is 0.74% based on an annual payout of $2.00 per share.
NTRA (Natera, Inc.) — 0.74% Dividend Yield Analysis
Natera, Inc. (NTRA) is a healthcare stock currently trading at $271.10 with a dividend yield of 0.74%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.